ReviewCancer biology & therapy2020

Significant response to apatinib monotherapy in heavily pretreated advanced HER2-positive breast cancer: a case report and literature review.

Li Danni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.